(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LEMZKYO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LEMZKYO

ST13

US500000079295544

Class

5

Filing

79295544

Registration

6504557

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

06/25/2026

Trademark type

Word

Nice classes

5

Filing date

08/26/2020

Registration date

10/05/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/05/2021

Last transaction

06/25/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

09

Owner location

E-28037 Madrid, ES

Examiner

SMITH, TARYN E

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

LABORATORIOS FARMACEUTICOS ROVI, S.A.

Representatives

Andrew M. Smith Resonate IP, LLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical productsantibioticsanalgesicsanestheticsamino acids for medical useantisepticstranquilizerscollyriumsdigestives for pharmaceutical purposeslaxatives; chemical products for medical usebeing pharmaceuticals for treating schizophrenia; chemical pharmaceuticals preparations for the treatment of diseases of the central nervous system; tonics being medicines for the treatment of headache; tranquillizers; soporifics; antipsychotics; medicated serums for the treatment of eczema; hormones; oral contraceptives; vaccinessyringesvialscartridges or carpules and ampoules for medical purposes containing pharmaceutical products in the nature of antipsychotics; pharmaceutical implants for delivering insulinimplantable subcutaneous drug delivery devices sold filled with insulin; sustained release medicine implants for delivering contraceptivesimplantable subcutaneous sustained release drug delivery devices sold filled with pharmaceutical preparations for contraceptive use; oncological preparations being pharmaceuticals for the treatment of cancer; preparations for the treatment of diseases of the central nervous system; preparations for the treatment of schizophrenia; preparations for the treatment of hormonal disorders; pharmaceutical preparations for the treatment of allergiesfor the treatment of the skin woundsthrombosiscoagulation diseasesinfectionsinfluenzapain and inflammation; tranquilizersantidepressantsanxiolytics; chemical products for medical usebeing pharmaceuticals for treating schizophrenia; chemical pharmaceuticals for the treatment of diseases of the central nervous system; disposable syringes sold pre-filled with pharmaceutical preparations for treatment of central nervous system diseases

Publications

History of USPTO decisions and trademark events.

33 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/25/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/27/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/27/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/27/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/27/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/27/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/15/2022

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

03/24/2022

XXCR

GENERIC MADRID TRANSACTION CREATED

03/24/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/05/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

10/05/2021

GPNX

NOTIFICATION PROCESSED BY IB

08/01/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/20/2021

PUBO

PUBLISHED FOR OPPOSITION

07/20/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

07/09/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

06/30/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/30/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/14/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/03/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/03/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/03/2021

RFNT

REFUSAL PROCESSED BY IB

02/21/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/03/2021

RFRR

REFUSAL PROCESSED BY MPU

02/03/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/16/2021

CNRT

NON-FINAL ACTION WRITTEN

01/15/2021

DOCK

ASSIGNED TO EXAMINER

12/27/2020

LIME

LIMITATION FROM THE IB - REQUEST EXAM REVIEW

12/11/2020

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

12/04/2020

MAFR

APPLICATION FILING RECEIPT MAILED

10/24/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/20/2020

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

10/15/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/08/2020

Continuous trademark protection

Get notified about every new filing that threatens LEMZKYO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.